Concord Biotech Q2 FY26 earnings call recording now available
Concord Biotech Limited announced the availability of the audio recording for its earnings call held on November 14, 2025. The call discussed the unaudited standalone and consolidated financial results for the second quarter and half-year period concluding September 30, 2025. The company previously informed stock exchanges about this earnings call on November 8, 2025.
The audio recording is hosted on the company's website and can be accessed directly via the provided link: https://concordbiotech.com/wp-content/uploads/2025/11/Q2FY26-Earning-Call-Audio.mp3. This release is made in accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015.
The announcement was issued by Ms. Hina Patel, company secretary and compliance officer, on November 15, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Concord Biotech publishes news
Free account required • Unsubscribe anytime